Portal de investigación
SEOM clinical guidelines on cardiovascular toxicity (2018)
Fecha de publicación:
Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Virizuela, JA
- Garcia, AM
- de las Penas, R
- Andres, R
- Beato, C
- de la Cruz, S
- Gavila, J
- Gonzalez-Santiago, S
- Fernandez, TL
Grupos
Abstract
One of the most common side effects of cancer treatment is cardiovascular disease, which substantially impacts long-term survivor's prognosis. Cardiotoxicity can be related with either a direct side effect of antitumor therapies or an accelerated development of cardiovascular diseases in the presence of preexisting risk factors. Even though it is widely recognized as an alarming clinical problem, scientific evidence is scarce in the management of these complications in cancer patients. Consequently, current recommendations are based on expert consensus. This Guideline represents SEOM's ongoing commitment to progressing and improving supportive care for cancer patients.
Datos de la publicación
- ISSN/ISSNe:
- 1699-048X, 1699-3055
- Tipo:
- Article
- Páginas:
- 94-105
- PubMed:
- 30627982
- Factor de Impacto:
- 0,833 SCImago ℠
- Cuartil:
- Q2 SCImago ℠
Clinical & Translational Oncology SPRINGER INT PUBL AG
Citas Recibidas en Web of Science: 21
Documentos
- No hay documentos
Filiaciones
Keywords
- Chemotherapy; Cardiotoxicity; Early detection; Risk assessment; Cancer
Campos de Estudio
Cita
Virizuela JA,Garcia AM,de las Penas R,SANTABALLA A,Andres R,Beato C,de la Cruz S,Gavila J,Gonzalez S,Fernandez TL. SEOM clinical guidelines on cardiovascular toxicity (2018). Clin. Transl. Oncol. 2019. 21. (1):p. 94-105. IF:2,737. (3).